Nuveen Core Plus Impact Fund of Beneficial Interest (NPCT) Financials
$9.71
As on 04-Sep-2026 15:50EDT
Market cap
$280 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
10.8
P/B Ratio
0.9
Div. Yield
0 %
Income Statement ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
35.28
|
29.23
|
21.01
|
-176.68
|
--
|
--
|
|||||
|
Cost of Revenue
|
9.21
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Gross Profit
|
26.07
|
29.23
|
21.01
|
-176.68
|
--
|
--
|
|||||
|
Operating Expenses
|
0.43
|
0.88
|
21.01
|
0.33
|
--
|
--
|
|||||
|
Operating Profit (EBIT)
|
25.64
|
28.35
|
20.42
|
-177.02
|
--
|
--
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
25.64
|
28.35
|
20.42
|
-177.02
|
--
|
--
|
|||||
|
Provision for Tax
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit after Tax (Net Income)
|
25.64
|
28.35
|
20.42
|
-177.02
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
Liabilities ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
321.97
|
334.83
|
343.35
|
352.72
|
565.28
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
184.12
|
184.46
|
193.22
|
151.57
|
304.91
|
--
|
|||||
|
Current Liabilities
|
0.30
|
0.99
|
0.39
|
0.40
|
2.65
|
--
|
|||||
|
Total Liabilities
|
506.39
|
520.29
|
536.96
|
575.16
|
873.83
|
--
|
Assets ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
506.39
|
520.24
|
530.48
|
567.78
|
866.90
|
--
|
|||||
|
Current Assets
|
0.00
|
0.05
|
6.48
|
7.33
|
6.88
|
--
|
|||||
|
Total Assets
|
506.39
|
520.29
|
536.96
|
575.16
|
873.83
|
--
|
|||||
|
Total Debt*
|
113.84
|
114.63
|
122.73
|
151.57
|
304.91
|
--
|
|||||
|
Net Current Assets
|
--
|
--
|
--
|
--
|
--
|
--
|
Cashflow ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
40.36
|
45.82
|
58.91
|
119.74
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
-39.24
|
-44.88
|
-58.74
|
-119.38
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
5.79
|
6.19
|
4.21
|
-25.76
|
--
|
|||||
|
ROE (%)
|
--
|
7.81
|
8.36
|
5.87
|
-38.57
|
--
|
|||||
|
ROA (%)
|
--
|
4.99
|
5.36
|
3.67
|
-24.43
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
100.19
|
--
|
|||||
|
Net Margin (%)
|
--
|
72.66
|
97.00
|
97.16
|
100.19
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
0.21
|
0.39
|
1.12
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
--
|
-9.57
|
38.85
|
111.53
|
--
|
--
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
18.30
|
10.18
|
10.51
|
10.08
|
10.36
|
--
|
|||||
|
High Price ($)
|
20.15
|
11.31
|
11.97
|
11.74
|
18.42
|
--
|
|||||
|
Low Price ($)
|
17.83
|
9.77
|
9.86
|
8.58
|
9.66
|
--
|
|||||
|
Market Cap ($ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.35
|
0.34
|
0.36
|
0.43
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
--
|
0.00
|
0.05
|
16.43
|
18.49
|
--
|
|||||
|
Quick Ratio
|
--
|
--
|
--
|
0.00
|
--
|
--
|
|||||
|
Interest Coverage
|
--
|
--
|
--
|
--
|
-31.60
|
--
|
Operating Efficiency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
18.38
|
30.82
|
-3.89
|
--
|
|||||
|
Asset Turnover
|
--
|
0.07
|
0.06
|
0.04
|
-0.24
|
--
|
|||||
|
Receivable days
|
--
|
55.62
|
74.04
|
116.08
|
-14.13
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
17.16
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|